<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00278967</url>
  </required_header>
  <id_info>
    <org_study_id>F38-26</org_study_id>
    <nct_id>NCT00278967</nct_id>
  </id_info>
  <brief_title>An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects</brief_title>
  <official_title>An Efficacy Evaluation of 2 Different Bowel Cleansing Preparations in Adult Subjects</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Braintree Laboratories</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Braintree Laboratories</source>
  <brief_summary>
    <textblock>
      To compare the safety and efficacy of 2 different bowel cleansing preparations prior to
      colonoscopy in adult subjects.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of the study is to evaluate the efficacy of 2 different HalfLytely preparations to
      produce a clinically acceptable degree of cleansing of the bowel, sufficient for colonoscopy.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2006</start_date>
  <completion_date>August 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Efficacy - preparation quality using a 4-point scale</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Safety - patient-reported preparation related side-effects</measure>
  </secondary_outcome>
  <enrollment>450</enrollment>
  <condition>Colonoscopy</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HalfLytely with Bisacodyl Tablets Bowel Prep Kit</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>HalfLytely - Reformulation</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        - Male or female outpatients who are undergoing colonoscopy for the following routinely
        accepted indications:

        Evaluation of BE results GI bleeding Anemia of unknown etiology Neoplastic disease
        surveillance Endosonography Inflammatory bowel disease Unknown diarrhea or constipation
        etiology Polypectomy Laser therapy Routine Screening

          -  At least 18 years of age

          -  Otherwise in good health, as determined by physical exam and medical history

          -  If female, and of child-bearing potential, is using an acceptable form of birth
             control (hormonal birth control, IUD, double-barrier method, depot contraceptive,
             sterilized, abstinent, or vasectomized spouse)

          -  Negative urine pregnancy test at screening, if applicable

          -  In the Investigatorâ€™s judgment, subject is mentally competent to provide informed
             consent to participate in the study

        Exclusion Criteria:

          -  Subjects with known or suspected ileus, gastrointestinal obstruction, gastric
             retention, bowel perforation, toxic colitis, or toxic megacolon

          -  Subjects with impaired consciousness that predisposes them to pulmonary aspiration

          -  Subjects who are undergoing colonoscopy for foreign body removal and decompression

          -  Subjects with pre-existing electrolyte disturbances, such as dehydration, or those
             secondary to the use of diuretics

          -  Subjects who are taking drugs that may affect electrolyte levels

          -  Subjects taking laxatives or prokinetic agents that refuse to discontinue these
             treatments for the duration of the study

          -  Subjects with known clinically significant electrolyte abnormalities such as
             hypernatremia, hyperphosphatemia, hypokalemia, or hypocalcemia

          -  Subjects who are pregnant or lactating, or intending to become pregnant during the
             study

          -  Subjects of childbearing potential who refuse a pregnancy test

          -  Subjects who are allergic to any preparation components

          -  Subjects who, in the opinion of the Investigator, should not be included in the study
             for any reason, including inability to follow study procedures

          -  Subjects who have participated in an investigational clinical, surgical, drug, or
             device study within the past 30 days
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Goldstein, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Long Island GI Research Group</affiliation>
  </overall_official>
  <location>
    <facility>
      <address>
        <city>Anaheim</city>
        <state>California</state>
        <zip>92801</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Jupiter</city>
        <state>Florida</state>
        <zip>33458</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Miami</city>
        <state>Florida</state>
        <zip>33173</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70809</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Laurel</city>
        <state>Maryland</state>
        <zip>20707</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Great Neck</city>
        <state>New York</state>
        <zip>11023</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Raleigh</city>
        <state>North Carolina</state>
        <zip>27612</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Germantown</city>
        <state>Tennessee</state>
        <zip>38138</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Bellevue</city>
        <state>Washington</state>
        <zip>98004</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <address>
        <city>Spokane</city>
        <state>Washington</state>
        <zip>99207</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>October 2006</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 13, 2006</study_first_submitted>
  <study_first_submitted_qc>January 13, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 19, 2006</study_first_posted>
  <last_update_submitted>October 18, 2006</last_update_submitted>
  <last_update_submitted_qc>October 18, 2006</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 19, 2006</last_update_posted>
  <keyword>colonoscopy</keyword>
  <keyword>preparation</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bisacodyl</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

